Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs GE Vernova Inc (GEV) Price & Performance

AbCellera Biologics IncTrade
GE Vernova IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs GE Vernova Inc — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while GE Vernova Inc trades at $1,026.43 (market cap $269.50B). The key difference: GE Vernova Inc is far larger — about 90.1× AbCellera Biologics Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLGEV
Market Cap
$2.99B$269.50B
Sector
HealthTechnology
52-Week High
$9.76$1.17K
52-Week Low
$2.78$547.96
Enterprise Value
$2.58B$259.17B
Dividend Yield
0.2%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV